Company profile
Omixon
Our mission: enabling histocompatibility labs to turn the benefits of innovative techs into better transplant outcomes
- Industry
- Biotechnology Research
- Employees
- 52
- Headquarters
- Budapest
- Founded
- 2011
- Office locations
- 2
Omixon company summary
Omixon is a company in the Biotechnology Research industry, headquartered in Budapest, founded in 2011. On LinkedIn the company has around 52 employees. The company lists 2 office locations. Its listed specialties include data analysis, next-generation sequencing, software development, NGS, HLA typing.
What technology does Omixon use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Omixon
Omixon is a global transplantation diagnostic company with a mission to provide histocompatibility laboratories with innovative technologies to improve transplant outcomes. Omixon is headquartered in Budapest, Hungary, with operations in the United States, Brazil and the Netherlands serving more than 100 laboratories worldwide. Building on multidisciplinary competences in bioinformatics, software engineering, molecular biology and regulatory science, Omixon transforms molecular biology innovations into state-of-the-art products in transplant diagnostics. Omixon was the first to successfully introduce NGS-based HLA typing kit and software in 2014 by bringing Holotype HLA, an NGS-based HLA genotyping product, and HLA Twin software to market. Omixon Twin delivers the most accurate high-resolution HLA genotyping and is used in more than 100+ laboratories worldwide. Omixon was the first to release a high-resolution HLA genotyping product NanoTYPE HLA™ with less than 5 hours turnaround time on the Oxford Nanopore sequencing platform complemented by NanoTYPER™ analysis software. Omixon is the first to bring to market the first donor-derived cell-free DNA kit HoloGRAFT for laboratories with donor-informative genetic markers with primer and probe sequences that are absent in the patient genotype by design. On October 16, 2024, in Barcelona, Spain, Werfen announced the completion of its acquisition of Omixon, after securing all required regulatory and antitrust approvals.
Specialties
Where is Omixon located?
Omixon lists 2 office locations.
Compare companies similar to Omixon
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Omixon omixon.com | Biotechnology Research | 52 | 2011 | Budapest |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Omixon
What does Omixon do?
Omixon is a global transplantation diagnostic company with a mission to provide histocompatibility laboratories with innovative technologies to improve transplant outcomes. Omixon is headquartered in Budapest, Hungary, with operations in the United States, Brazil and the Netherlands serving more than 100 laboratories worldwide. Building on multidisciplinary competences in bioinformatics, software engineering, molecular biology and regulatory science, Omixon transforms molecular biology innovations into state-of-the-art products in transplant diagnostics. Omixon was the first to successfully introduce NGS-based HLA typing kit and software in 2014 by bringing Holotype HLA, an NGS-based HLA genotyping product, and HLA Twin software to market. Omixon Twin delivers the most accurate high-resolution HLA genotyping and is used in more than 100+ laboratories worldwide. Omixon was the first to release a high-resolution HLA genotyping product NanoTYPE HLA™ with less than 5 hours turnaround time on the Oxford Nanopore sequencing platform complemented by NanoTYPER™ analysis software. Omixon is the first to bring to market the first donor-derived cell-free DNA kit HoloGRAFT for laboratories with donor-informative genetic markers with primer and probe sequences that are absent in the patient genotype by design. On October 16, 2024, in Barcelona, Spain, Werfen announced the completion of its acquisition of Omixon, after securing all required regulatory and antitrust approvals.
How many employees does Omixon have?
Omixon has around 52 employees on LinkedIn.
Where is Omixon headquartered?
Omixon is headquartered in Budapest.
Where does Omixon have offices?
Omixon lists 2 office locations, including Budapest, 1117, HU; Boston, Massachusetts, US.
When was Omixon founded?
Omixon was founded in 2011.
Build a lead list from companies like Omixon
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.